STAAR Surgical Company (STAA) Stock Grade

About STAAR Surgical Company's fundamentals

STAAR Surgical is a small-cap medical device company with a $1.0B market valuation that is currently unprofitable, reporting a net loss in its latest annual statement and operating at a -33.6% net margin. The company's revenue declined 23.7% year-over-year, indicating significant contraction in its top line. With a P/E ratio of 1571.8—an extremely elevated multiple reflecting the company's negative earnings—and no dividend yield, the company is reinvesting any available capital into operations rather than returning funds to shareholders. Return on equity is not calculable given the company's loss position.